December 17, 2020
Binswanger Secures Buyer For 25,032 SF Industrial Property In West Conshohocken

Beechnut Capital bought the property for $3,000,000 and will Occupy 11K SF

November 5, 2020
Binswanger Announces Expansion Of Utopia Fulfillment’s Lease At The Pennsauken Logistics Center – Only Two Months After Initially Occupying Space

Velocity Ventures Leases An Additional 103,275 Sf To The E-Commerce Company   PHILADELPHIA, PA – November 5, 2020

October 27, 2020
Binswanger Continues Industrial Property Sales Momentum Selling Two Properties – One In Darby, Pa, A Second In North Philadelphia

Despite COVID-induced Market Uncertainty, Industrial Properties in the Region Continue to Attract Buyers  

October 8, 2020
Binswanger Sells Two Properties in Montgomery and Bucks County

The Sale Underscores the Momentum for Industrial Properties in Pennsylvania’s Bucks and Montgomery Counties   PHILADELPHIA

October 6, 2020
Binswanger Sells Two Industrial Properties In Pennsauken, NJ

Despite Pandemic, Demand for Industrial Facilities In New Jersey Continues to be High PHILADELPHIA, PA

September 24, 2020
Binswanger Named Exclusive Agent for 3.3 Million SF Industrial and Rail Park in Nuevo Laredo, Mexico

The 16-building portfolio offers a consistent and growing cash flow with leases in US dollars from world-class companies including Rheem, Cat

August 6, 2020
Binswanger Announces Tenant, Utopia Fulfillment, Taking Space In 8600 River Road In Pennsauken, NJ

The 355,000 SF facility, purchased and recently renovated by Velocity Venture Partners, is the largest industrial building available for lease in Pennsauken

July 30, 2020
Binswanger and Cushman & Wakefield Marketing Unique 14-Acre Development Site in Stamford, CT Called “Peninsula at Harbor Point”

1,000,000-SF Site Located in Live-Work-Play Master Plan Community with Tremendous Waterfront Access

June 1, 2020
Binswanger Secures Buyer for AstraZeneca’s former 178,713 SF Biopharma Manufacturing Facility in Boulder, CO

The highly specialized building, sold to AGC Biologics, will be used as a contract manufacturing biopharma facility to produce generi